New diagnostic index for prediction of severe irAEs in patients with metastatic melanoma taking checkpoint inhibitors.

被引：0
|
作者：
Zhukova, Natalia V.
Orlova, Rashida
Malkova, Anna
Kaledina, Ekaterina
Demchenkova, Alexandra
Naymushina, Polina
Nazarov, V.
Mazing, A.
Lapin, S.
Beliak, Natalia P.
Shoenfeld, Y.
机构：
[1] St Petersburg State Univ, Fac Med, St Petersburg, Russia
[2] St Petersburg State Univ, St Petersburg, Russia
[3] SPb SBIH, City Clin Oncol Dispensary, St Petersburg, Russia
[4] Pavlov First St Petersburg State Med Univ, St Petersburg, Russia
[5] Ariel Univ, Ariel, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21565
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Evaluation of the modified immune prognostic index to prognosticate outcomes in metastatic uveal melanoma patients treated with immune checkpoint inhibitors
    Sander, Michael S.
    Stukalin, Igor
    Vallerand, Isabelle A.
    Goutam, Siddhartha
    Ewanchuk, Benjamin W.
    Meyers, Daniel E.
    Pabani, Aliyah
    Morris, Don G.
    Heng, Daniel Y. C.
    Cheng, Tina
    CANCER MEDICINE, 2021, 10 (08): : 2618 - 2626
  • [32] Prediction of immune checkpoint blockade-related hepatitis in metastatic melanoma patients
    Schilling, Hannah-Lou
    Hutchinson, James A.
    Haferkamp, Sebastian
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (06): : 773 - 775
  • [33] Incidence of New Primary Cutaneous Melanoma in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors A Single-Center Cohort Study
    Nanda, Japbani K.
    Dusza, Stephen W.
    Navarrete-Dechent, Cristian
    Liopyris, Konstantinos
    Marghoob, Ashfaq A.
    Marchetti, Michael A.
    JAMA DERMATOLOGY, 2021, 157 (01) : 79 - 83
  • [34] Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET–CT
    Antonia Dimitrakopoulou-Strauss
    Cancer Immunology, Immunotherapy, 2019, 68 : 813 - 822
  • [35] The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series
    Xizhi Wen
    Ya Ding
    Jingjing Li
    Jingjing Zhao
    Ruiqing Peng
    Dandan Li
    Baoyan Zhu
    Yao Wang
    Xing Zhang
    Xiaoshi Zhang
    Cancer Immunology, Immunotherapy, 2017, 66 : 1153 - 1162
  • [36] The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors
    Dravillas, Caroline E.
    Coleman IV, Samuel S.
    Hoyd, Rebecca
    Caryotakis, Griffin
    Denko, Louis
    Chan, Carlos H. F.
    Churchman, Michelle L.
    Denko, Nicholas
    Dodd, Rebecca D.
    Eljilany, Islam
    Hardikar, Sheetal
    Husain, Marium
    Ikeguchi, Alexandra P.
    Jin, Ning
    Ma, Qin
    McCarter, Martin D.
    Osman, Afaf E. G.
    Robinson, Lary A.
    Singer, Eric A.
    Tinoco, Gabriel
    Ulrich, Cornelia M.
    Zakharia, Yousef
    Spakowicz, Daniel
    Tarhini, Ahmad A.
    Tan, Aik Choon
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (08): : 1978 - 1990
  • [37] Real-world analyses of therapy discontinuation of checkpoint inhibitors in metastatic melanoma patients
    Marina Amaral de Ávila Machado
    Cristiano Soares de Moura
    Kelvin Chan
    Jeffrey R. Curtis
    Marie Hudson
    Michal Abrahamowicz
    Rahima Jamal
    Louise Pilote
    Sasha Bernatsky
    Scientific Reports, 10
  • [38] Real-world analyses of therapy discontinuation of checkpoint inhibitors in metastatic melanoma patients
    Machado, Marina Amaral de Avila
    de Moura, Cristiano Soares
    Chan, Kelvin
    Curtis, Jeffrey R.
    Hudson, Marie
    Abrahamowicz, Michal
    Jamal, Rahima
    Pilote, Louise
    Bernatsky, Sasha
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors
    Lai-Kwon, J. E.
    Khoo, C.
    Lo, S.
    Milne, D.
    Mohamed, M.
    Raleigh, J.
    Smith, K.
    Lisy, K.
    Sandhu, S. K.
    Jefford, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [40] Sudden Otovestibular Dysfunction in 3 Metastatic Melanoma Patients Treated With Immune Checkpoint Inhibitors
    Stuermer, Suzan H.
    Lechner, Axel
    Berking, Carola
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (05) : 193 - 197
12345